Oncology value based payment models: Where are the savings opportunities?

Authors

null

Era Kim Oh

United Healthgroup, Minneapolis, MN

Era Kim Oh, Jon Maguire, Tracy E. Spinks, Kristen K. McNiff Landrum, Jennifer Malin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cost, Value, and Policy; Health Equity and Disparities; Patient Experience

Track

Cost, Value, and Policy,Technology and Innovation in Quality of Care,Health Care Access, Equity, and Disparities,Patient Experience,Quality, Safety, and Implementation Science

Sub Track

Value/Cost of Care

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 69)

DOI

10.1200/JCO.2020.39.28_suppl.69

Abstract #

69

Poster Bd #

C7

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Use of novel cancer staging model to analyze healthcare costs of commercially insured patients with colorectal cancer.

Use of novel cancer staging model to analyze healthcare costs of commercially insured patients with colorectal cancer.

First Author: Rebecca Smith

Poster

2019 Genitourinary Cancers Symposium

Prostate cancer cost-of-care and evaluation of traditional cost control measures.

Prostate cancer cost-of-care and evaluation of traditional cost control measures.

First Author: Dhruv Bansal

Poster

2012 ASCO Quality Care Symposium

Preliminary decision-tree analysis of costs to payors associated with a pancreatic multidisciplinary clinic.

Preliminary decision-tree analysis of costs to payors associated with a pancreatic multidisciplinary clinic.

First Author: Shereef Elnahal

Poster

2022 ASCO Annual Meeting

Market determinants of commercial prices for intravenous chemotherapy infusions.

Market determinants of commercial prices for intravenous chemotherapy infusions.

First Author: Michael Milligan